首页> 外文OA文献 >A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.

【2h】

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.

机译：Ib / II期研究评估每周多西紫杉醇和顺铂联合卡培他滨和贝伐单抗治疗晚期食管癌的疗效。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Baruch Brenner; Michal Sarfaty; Ofer Purim; Yulia Kundel; Limor Amit; Amir Abramovich; Udi Sadeh Gonik; Efraim Idelevich; Noa Gordon; Gal Medalia; Aaron Sulkes;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 奥沙利铂和卡培他滨联合贝伐单抗加放疗的新辅助方案治疗局部晚期直肠癌:单中心Ⅱ期研究结果 [J] . Xin Yu, De-sen Wan, Pei-rong Ding, 癌症（英文版） . 2018,第008期
2. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. [J] . Kang YK, Ryu MH, Yoo C, Cancer chemotherapy and pharmacology. . 2011,第6期

机译：I / II期研究联合多西他赛，卡培他滨和顺铂（DXP）作为晚期胃癌患者的一线化疗药物。
3. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. [J] . Sym SJ, Ryu MH, Kang HJ, Cancer chemotherapy and pharmacology. . 2010,第2期

机译：一期为期3周的多西他赛，卡培他滨和奥沙利铂联合化疗在未经治疗的晚期胃癌患者中的研究。
4. Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer. [J] . Wang B, Zhang W, Hong X, Cancer chemotherapy and pharmacology. . 2009,第2期

机译：在晚期胃癌患者中，连续24小时连续输注5-氟尿嘧啶与每周多西他赛和顺铂联合进行24小时的I期剂量递增研究。
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
7. A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer [O] . Baruch Brenner, Michal Sarfaty, Ofer Purim, -1

机译：Ib / II期研究评估晚期食管胃癌患者每周多西他赛和顺铂联合卡培他滨和贝伐单抗联合治疗的研究
8. A Multicenter Randomized Phase III Trial to Compare Weekly Usage with Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemo-radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer. [O] . L. Jiang, G. Zhu, J. Wang, 2019

机译：多中心随机阶段III试验，将每周用法与多西紫杉醇和顺铂进行三周用途，同时使用局部晚期非小细胞肺癌患者进行同步化疗。

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.

著录项

相似文献

相关主题

期刊订阅